Drug Database
Back to search

Netherlands· NL-a38ed13ecf18

Wilzin 25 mg, harde capsules

A zinc acetate product containing zinkdiacetaat 2-water (e 650), registered in Netherlands by Orphan Europe SARL. The same ATC class is registered in 9 of our 19 countries.

ATC A16AX05

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedWilzin 25 mg, harde capsulesATCA16AX05REGISTER NO.NL-a38ed13ecf18PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about zinkdiacetaat 2-water (e 650)Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Zinc acetate is registered in 9 of 19 countries.

Countries holding a registration under ATC A16AX05 (zinc acetate), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 6 of them publish a price we can compare per daily dose
Search zinc acetate products by name

Zinc acetate · ATC A16AX05

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
ZINKDIACETAAT 2-WATER (E 650)
Manufacturer
Orphan Europe SARL
Country
Netherlands (NL)
ATC code
A16AX05
ATC class
Zinc acetate
Defined daily dose
0.15 g, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/04/286

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

124 interactions on record for zinc acetate.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check zinc acetate against other medicinesHow interaction checks work

Zinc acetate · interactions on record

124 records

  • 4 severe
  • 31 moderate
  • 89 minor

Most severe, free to view

  • RaltegravirJ05AJ01severe
  • ElvitegravirJ05AJ02severe
  • RaltegravirJ05AX08severe
  • ElvitegravirJ05AX11severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Zinc acetate in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All zinc acetate products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

  • Austria · Labisan, Zink Aguettant
  • Belgium · Unguentum, Zinc Aguettant
  • Germany · Biolectra, Cefazink
  • Denmark · Zipzoc
  • Spain · Pasta Lassar Imba
  • Finland · Zipzoc
  • France · Effizinc, Oligosol
  • United Kingdom (Northern Ireland) · Solvazinc, Zinc & Castor Oil L.C.M
  • Greece · Zincalto, Zinctin
  • Ireland · Caldease, Zinc Ovelle
  • Iceland · Wilzin
  • Italy · Zinco Ossido Marco Viti, Zinco Ossido Nova Argentia
  • Liechtenstein · Wilzin
  • Luxembourg · Cefazink, Oligosol
  • Latvia · Cinka Rff
  • Norway · Wilzin
  • Poland · Maść Cynkowa,, Maść Z Tlenkiem Cynku
  • Portugal · Halibut, Lassadermil
  • Sweden · Zipzoc
  • Slovakia · Tekutý Púder

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f25a4c31-5f86-41e5-994c-a790183857ff
GET /v1/drugs/f25a4c31-5f86-41e5-994c-a790183857ff?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, hard",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/wilzin-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Zinc Acetate",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp71841",
  "excipients": [
    "AMMONIA (E 527)",
    "BRILJANTBLAUW FCF (E 133)",
    "GELATINE (E 441)",
    "IJZEROXIDE ZWART (E 172)",
    "KALIUMHYDROXIDE (E 525)",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL",
    "PROPYLEENGLYCOL (E 1520)",
    "SCHELLAK (E 904)",
    "TITAANDIOXIDE (E 171)",
    "ZWARTE INKT"
  ],
  "substances": [
    "ZINKDIACETAAT 2-WATER (E 650)"
  ],
  "leaflet_url": null,
  "authorised_at": "2004/10/13",
  "procedure_number": "EMEA/H/C/000535",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/04/286",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about zinc acetate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console